Approval · Notice of Compliance 5168 · 1994
PENTASA: Notice of Compliance 5168
Issued June 28, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5168
- Date
- June 28, 1994
- Company
- Marion Merrell Dow (Canada) Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Gastrointestinal anti-inflammatory
Products in this notice
Medicinal ingredients
- MESALAZINE 250 MG per TAB
- MESALAZINE 500 MG per TAB
- MESALAZINE 250 MG per CAP